Lantheus Holdings (LNTH) FCF Margin (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly FCF Margin of 32.31% for Q1 2026, up 502.0% year-over-year from 5.37% in Q1 2025, and up 121.22% quarter-over-quarter from 14.6% in Q4 2025.
Lantheus Holdings (LNTH) FCF Margin (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported FCF Margin for 13 consecutive years, with 32.31% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin rose 502.0% year-over-year to 32.31%; the TTM figure through Mar 2026 stood at 24.2% (down 970.0% YoY), while the FY2025 annual figure was 22.97%, down 1222.0% from the prior year.
- FCF Margin rose to 32.31% in Q1 2026 per LNTH's latest filing, from 14.6% in the prior quarter.
- Across five years, FCF Margin topped out at 1004.36% in Q4 2023 and bottomed at 13.58% in Q2 2023.
- Historically, FCF Margin has averaged 83.96% across 5 years, with a median of 30.51% in 2022.
- Annual changes were most pronounced in 2023 — FCF Margin soared 97130 bps — and 2024, when it tumbled 94464 bps.
- Lantheus Holdings' FCF Margin stood at 33.06% in 2022, then surged by 2938 bps to 1004.36% in 2023, then tumbled by 94 bps to 59.72% in 2024, then plunged by 76 bps to 14.6% in 2025, then soared by 121 bps to 32.31% in 2026.
- Business Quant data shows LNTH's FCF Margin at 32.31% in Q1 2026, 14.6% in Q4 2025, and 26.03% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 23.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.15% |
| Mar 31, 2026 | 32.31% |
| Dec 31, 2025 | 14.60% |
| Sep 30, 2025 | 26.03% |
| Jun 30, 2025 | 24.59% |
| Mar 31, 2025 | 27.28% |
| Dec 31, 2024 | 59.72% |
| Sep 30, 2024 | 33.81% |
| Jun 30, 2024 | 14.63% |
| Mar 31, 2024 | 32.54% |
| Dec 31, 2023 | 1,004.36% |
| Sep 30, 2023 | 28.52% |
| Jun 30, 2023 | -13.58% |
| Mar 31, 2023 | 33.27% |
| Dec 31, 2022 | 33.06% |
| Sep 30, 2022 | 42.25% |
| Jun 30, 2022 | 30.51% |
| Mar 31, 2022 | 3.39% |
| Dec 31, 2021 | 1.35% |
| Sep 30, 2021 | 4.25% |